Increasing HIV Testing in Urban Emergency Departments Via Mobile

Status Not yet recruiting

Clinical Trial Summary

Because people with undiagnosed HIV will not receive treatment and may unknowingly infect others, the investigators propose a mobile computer-based video intervention to increase HIV test rates in high volume urban hospital emergency departments (EDs). EDs offer important points of contact for many of those at greatest risk for HIV. Unfortunately, when ED patients are offered routine HIV testing, most decline. Our proposed intervention builds upon initial findings from a trial our research team conducted with patients who declined HIV testing. The intervention, grounded in the Information-Motivation and Behavioral Skills model (IMB), showed an onscreen physician explaining the importance of HIV testing (to build knowledge and motivation) and modeling a rapid HIV test (to increase motivation and behavioral skill). This brief intervention had a potent effect: a third accepted HIV testing post-intervention. While this preliminary study is highly encouraging, it revealed a number of other critical research questions. First, it remains unclear what intervention component most strongly contributed to patients' decisions to test: the video content or the offer of an HIV test by a computer rather than a person. Second, consistent with the literature, participants indicated a community member disclosing positive HIV status onscreen would increase the proportion of patients who test. Third, results suggest there is individual variation in the extent to which behavior is more strongly influenced by onscreen community members or experts (e.g. physicians). Therefore, the goal of the present study, guided by the IMB model, is to determine how the investigators can refine mobile computer-based interventions to maximize HIV testing rates among patients who initially decline to test in the ED. At the end of the computerized intervention, onscreen text will ask patients if they would agree to an HIV test. Those who agree will be tested by ED staff. The study's endpoint will be post-intervention HIV test rates. The investigators' study will inform scalable interventions for underserved populations nationwide.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Open Label

Related Conditions & MeSH terms

HIV Testing

Clinical Trial Details

NCT number	NCT02154802
Study type	Interventional
Source	National Development and Research Institutes, Inc.
Contact	Ian D Aronson, Ph.D.
Phone	212-845-4567
Email	aronson@ndri.org
Status	Not yet recruiting
Phase	N/A
Start date	July 2014

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04033718` - Inpatient Package to Reduce HIV and AIDS-related Death in Zambia	N/A
Withdrawn	`NCT03938077` - A Community-University Approach to Preventing HIV	N/A
Recruiting	`NCT05615935` - Experiential HIV Testing Increasing Testing Related Knowledge and Practice, and Reduce Stigma Toward HIV of Nurses.	N/A
Active, not recruiting	`NCT06150937` - HST for Female Sex Workers/Drug Users in Kazakhstan	N/A
Completed	`NCT01637324` - Multidisciplinary Services to Enhance HIV Testing and Linkage to Care Among MSM	N/A
Completed	`NCT05388084` - Peer Led Outreach to Engage Male Partners of Pregnant Women in Uganda (Okutuuka Study)	N/A
Active, not recruiting	`NCT05306938` - Adolescent Wellness Visits in Tanzania	N/A
Recruiting	`NCT05384145` - Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama	N/A
Recruiting	`NCT05020353` - OraQuick® HIV Self-Test Study in Canada	N/A
Active, not recruiting	`NCT02834572` - Using Technology to Match Young Black Men and Transwomen Who Have Sex With Men or Transwomen to HIV Testing Options	N/A
Completed	`NCT04210271` - Testing an Intervention to Increase HIV Self-Testing Among Young, Black MSM	N/A
Active, not recruiting	`NCT04810559` - Near Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole Blood	N/A
Completed	`NCT03939455` - Mobile Augmented Screening Tool to Increase Adolescent HIV Testing and Linkage to Care	N/A
Completed	`NCT05685498` - Peer-led HIV Self-testing Among Men in Two Ugandan Fishing Communities	N/A
Recruiting	`NCT04030689` - Free HIV Testing in Private Biological Laboratories: A New Offer to Encourage HIV Testing
Completed	`NCT02714140` - Does Preference-based HIV Testing Increase Uptake in High Risk Populations?	N/A
Completed	`NCT05107401` - Crowdsourcing to Reduce HIV Stigma Among Adolescents and Young Adults in Kazakhstan	N/A
Completed	`NCT01760057` - Evaluating the Effect of a Novel Web-based Intervention to Increase HIV Testing in Men Who Have Sex With Men	N/A
Completed	`NCT04754386` - Caregiver-Assisted Oral Fluid-based HIV Screening in Children: Zambia
Recruiting	`NCT03757104` - Home-based Intervention to Test and Start	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Increasing HIV Testing in Urban Emergency Departments Via Mobile Technology

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms